Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 12-2017 | 06-2017 | 12-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,533 | -20,703 | -11,550 | -27,326 | -11,770 |
| Depreciation Amortization | 1,263 | 3,299 | 1,630 | 5,902 | 3,080 |
| Other Working Capital | -1,685 | -1,852 | -2,200 | -164 | -190 |
| Other Operating Activity | 5,387 | 2,562 | -810 | 3,853 | -2,660 |
| Operating Cash Flow | $-10,568 | $-16,694 | $-12,930 | $-17,735 | $-11,540 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -431 | -911 | -560 | -1,826 | -1,070 |
| Other Investing Activity | 1 | -984 | -980 | 197 | 220 |
| Investing Cash Flow | $-430 | $-1,895 | $-1,540 | $-1,629 | $-850 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -423 | 13,245 | -120 | 20,675 | -230 |
| Financing Cash Flow | $-423 | $13,245 | $-120 | $20,675 | $-230 |
| Exchange Rate Effect | -636 | -333 | -5 | 632 | -200 |
| Beginning Cash Position | 17,971 | 22,693 | 22,510 | 21,922 | 23,200 |
| End Cash Position | 5,914 | 17,017 | 7,900 | 23,864 | 10,360 |
| Net Cash Flow | $-12,057 | $-5,676 | $-14,600 | $1,942 | $-12,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,568 | -16,694 | -12,930 | -17,735 | -11,540 |
| Free Cash Flow | -10,568 | -16,694 | -12,930 | -17,735 | -11,540 |